Concord Healthcare Group Co. Ltd. released its interim financial results for the six months ended June 30, 2025. The company reported a decrease in revenue by 8.3%, from RMB219.0 million in the same period of 2024 to RMB200.9 million in 2025. Despite the overall revenue decline, revenue from hospital operations saw an increase of 11.2%, rising from RMB137.8 million in 2024 to RMB153.2 million in 2025. The group achieved a turnaround in gross profit, reporting RMB0.4 million for the first half of 2025 compared to a gross loss of RMB34.5 million in the same period of the previous year. Net loss slightly decreased by 1.0%, with the figure standing at RMB200.0 million for the first half of 2025, down from RMB202.0 million in 2024. Concord Healthcare Group focuses on the high-end oncology healthcare sector and operates four offline self-operated hospitals. The company continues to manage its operations amidst the financial challenges, showing improvements in certain areas such as hospital revenue and gross profit.